Dawn Svoronos
No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Sep 1: option exercise (5,144 XENE shares).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Dawn Svoronos reported
None in the last 12 months, as filed.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Dawn Svoronos' companies
| Stock | Trades | Quality Score |
|---|---|---|
| 0 |
Alerts for Dawn Svoronos
Use this page
How to cite
Breakaway, Dawn Svoronos: Director at Xenon Pharmaceuticals (XENE), Sep 1, 2026, getbreakaway.com/insiders/dawn-svoronos
Journalists: email support@getbreakaway.com for the data behind this page.